The mechanism
GHRH signals the pituitary gland to release growth hormone. Sermorelin was designed to mimic that signal.
Evidence and limitations
Research in adults is limited. It does not support promises of growth hormone restoration, fat loss, muscle gain or anti-aging outcomes, and claims from other drugs or historical indications cannot be borrowed.
Regulatory status depends on the specific formulation and how it is prepared.
How Level Health approaches it
This page is educational. A clinical evaluation pathway for sermorelin is not currently confirmed. Enrollment is disabled until a verified service exists.
Sources
Clinical review: pending. Medical copy must be reviewed by a licensed clinician before publication.